小剂量西地兰在婴幼儿重症肺炎心力衰竭前期 给药的临床价值分析
 |
| 第1页 |
参见附件。
摘要：目的:探究在婴幼儿重症肺炎心力衰竭前期行小剂量西地兰治疗的临床价值，并进行分析。方法:对我院2011年12月~2013年12月住院部收治的86例重症肺炎患儿展开研究，将其按照不同的治疗方式分为研究组和对照组，对照组行常规治疗，研究组在对照组的基础上加用小剂量西地兰治疗，对比分析两组患儿的临床疗效。结果:研究组患儿心衰发生率为9.30%较对照组的39.53%低，两组患儿在心衰率、治疗总有效率的比较上χ2=10.5238、4.4444，p<0.05；在心率、呼吸恢复时间及住院时间的比较上t=5.8442、2.4992，p<0.05；差异具有统计学意义。结论:在婴幼儿重症肺炎心力衰竭前期行小剂量西地兰治疗有效降低了心衰的发生率，缩短病程，安全有效，具有很高的临床使用价值。
关键词：婴幼儿重症肺炎；西地兰；心力衰竭；临床价值
Abstract：Objective: To explore the clinical value of heart failure in infants with severe pneumonia earlier lines of small dose cedilanid therapy, and carries on the analysis. Method: 86 cases of children with severe pneumonia inpatients admitted in our hospital from 2011 December to ~2013 in December, according to the different treatment methods are divided into the study group and the control group, the control group received routine therapy, study group in the control group based on the use of small dose cedilanid therapy, compared two groups of clinical curative effects children. Results: the study group with heart failure rate was 9.30% compared with 39 ......
您现在查看是摘要介绍页，详见PDF附件。